10 Year Financial Data of Amedisys, Inc. (AMED)

11.05 (1y: +10%)

Market Cap	343 M	P/E(ttm)
Enterprise Value	421.63 M	P/B	0.80

AMED- NAS (USA)
Amedisys, Inc.

Currently 1/5

Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$11.05

2 Severe Warning Signs

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	21.8	1.8	-2.9
EBITDA Growth (%)	0	0	0
Free Cash Flow Growth (%)	9.7	-35.7	-78.9
Book Value Growth (%)	16.8	16.8	-16.7

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	10.61	12.58	17.92	24.28	26.56	44.14	54.52	57.38	51.24	49.77	47.81	12.45	12.61	12.35	11.95	10.90
EBITDA per Share	1.30	2.08	2.68	3.42	4.20	6.60	9.33	8.01	-15.03	-2.41	-2.65	0.76	0.85	0.81	-4.77	0.46
Free Cashflow per Share	1.49	1.36	1.09	0.62	2.45	4.37	7.42	4.91	3.39	0.71	1.38	0.05	0.44	0.33	-0.11	0.72
Earnings per Share ($)	0.62	1.13	1.41	1.72	2.48	3.22	4.89	3.95	-13.33	-2.79	-2.84	0.18	0.26	0.33	-3.52	0.09
Book Value per Share	3.83	8.22	9.05	16.33	17.01	20.87	26.48	30.82	18.08	15.13	14.80	17.75	17.99	18.23	14.90	14.80
Month End Stock Price	11.37	24.29	31.68	32.87	48.52	41.34	48.60	33.50	10.91	11.31	--	14.46	12.45	13.82	11.31	--
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	16.40	13.80	15.60	10.50	14.60	15.40	18.50	12.80	-73.70	-18.50	2.40	4.00	6.00	7.20	-94.40	2.40
Return on Assets %	9.10	10.30	8.90	8.20	11.10	8.10	11.60	8.70	-44.60	-11.40	1.60	2.40	3.60	4.40	-58.40	1.60
Return on Capital - Joel Greenblatt %	--	--	216	94.80	112	144	255	145	-325	-62.70	10.00	31.60	38.80	34.80	-346	10.00
Debt to Equity	0.16	0.03	0.33	0.02	0.05	0.59	0.29	0.21	0.28	0.23	0.17	0.26	0.24	0.22	0.23	0.17

Gross Margin %	58.90	57.70	57.30	56.50	55.80	52.60	52.10	49.80	46.80	43.50	43.20	43.80	43.90	43.00	43.20	43.20
Operating Margin %	10.10	14.70	13.10	12.10	13.80	13.20	15.20	11.80	-32.00	-7.50	1.20	3.40	4.10	3.90	-42.70	1.20
Net Margin %	5.90	9.00	7.90	7.10	9.30	7.30	9.00	6.90	-26.00	-5.60	0.80	1.50	2.10	2.60	-29.40	0.80

Days Sales Outstanding	38.90	39.30	65.20	50.50	50.40	54.00	36.20	31.60	36.80	41.50	38.80	39.70	39.20	39.60	42.40	38.80
Days Inventory	11.70	12.80	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Inventory Turnover	31.20	28.50	--	--	--	--	--	--	--	--	--	--	--	--	--	--

Debt to Revenue	0.06	0.02	0.17	0.01	0.03	0.28	0.14	0.11	0.10	0.07	0.23	0.37	0.34	0.33	0.28	0.23
COGS to Revenue	0.41	0.42	0.43	0.44	0.44	0.47	0.48	0.50	0.53	0.57	0.57	0.56	0.56	0.57	0.57	0.57
Inventory to Revenue	0.01	0.02	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Interest Exp. to Revenue %	-0.84	0.02	-0.39	-0.69	0.45	-1.31	-0.76	-0.54	-0.58	-0.81	-0.32	-0.56	-0.52	-0.53	-1.68	-0.32

Asset Turnover	1.54	1.14	1.12	1.17	1.19	1.11	1.29	1.26	1.71	2.04	0.48	0.43	0.44	0.43	0.50	0.48
Buyback Ratio	-274	-352	-18.30	-338	-9.70	-4.40	-3.90	-5.50	1.30	4.00	-39.20	-17.60	-12.80	-9.60	0.80	-39.20
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	142	227	382	541	698	1,187	1,513	1,634	1,470	1,488	1,456	371	378	376	363	339
Cost of Goods Sold	58.55	96.08	163	235	309	563	724	820	782	841	825	209	212	214	206	193
Gross Profit	83.92	131	219	306	389	625	789	814	688	647	631	162	166	161	157	147

Selling, General, &Admin. Expense	69.58	97.63	168	230	279	423	510	567	341	535	530	134	136	131	134	128
Earnings Before DDA	17.41	37.50	57.08	76.21	110	178	259	228	-431	-72.15	-80.48	22.62	25.45	24.66	-145	14.29

Depreciation, Depletion and Amortization	3.07	4.13	6.97	10.56	13.77	20.41	28.31	34.59	39.56	40.06	40.02	10.17	9.91	9.98	10.01	10.12

Operating Income	14.34	33.38	50.10	65.66	96.56	157	231	194	-471	-112	-120	12.46	15.55	14.68	-155	4.17
Interest Income/Expense	-1.20	0.04	-1.47	-3.71	3.15	-15.60	-11.46	-8.77	-8.59	-12.10	-11.14	-2.06	-1.98	-1.97	-6.10	-1.10
Net Income	8.41	20.50	30.10	38.26	65.11	86.68	136	113	-382	-83.59	-86.33	5.42	7.88	9.92	-107	2.68

Earnings per Share ($)	0.62	1.13	1.41	1.72	2.48	3.22	4.89	3.95	-13.33	-2.79	-2.84	0.18	0.26	0.33	-3.52	0.09
Total Shares Outstanding	13.43	18.06	21.29	22.29	26.28	26.90	27.76	28.48	28.69	29.90	31.10	29.78	30.03	30.42	30.36	31.10
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	29.78	89.68	17.23	84.22	56.19	2.85	34.49	120	48.00	14.55	7.02	41.29	37.16	39.11	14.55	7.02
Accounts Receivable	15.19	24.48	68.14	74.93	96.31	176	150	142	148	169	145	162	163	163	169	145
Inventory	1.88	3.38	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Other Current Assets	2.75	1.36	6.97	20.06	12.01	15.81	33.28	32.09	35.95	22.07	30.71	34.84	35.98	31.28	22.07	30.71
Total Current Assets	49.60	119	92.34	179	165	194	218	294	232	206	182	238	236	234	206	182

Property, Plant and Equipment	7.22	10.00	27.39	52.96	68.31	79.26	91.92	139	149	157	156	144	146	151	157	156
Intangible Assets	35.66	66.98	208	226	347	776	845	845	385	257	257	384	393	419	257	257
Other Long Term Assets	--	3.86	11.82	5.83	7.45	20.32	17.87	22.54	92.97	111	117	89.40	83.10	71.48	111	117
Total Assets	92.47	200	340	464	587	1,070	1,172	1,300	858	731	712	855	858	876	731	712

Accounts Payable	19.48	38.51	75.09	60.93	81.11	157	174	165	176	163	164	174	173	168	163	164
Current Portion of Long-Term Debt	5.19	2.11	20.70	3.22	11.05	42.63	44.25	37.18	33.89	35.81	35.81	68.51	60.70	54.31	35.81	35.81
Other Current Liabilities	9.35	1.35	4.17	17.77	9.58	4.66	11.25	14.29	11.75	5.61	3.40	10.19	11.07	9.25	5.61	3.40
Total Current Liabilities	34.02	41.98	99.96	81.92	102	205	229	216	222	205	203	252	245	231	205	203

Long-Term Debt	3.09	1.71	43.06	2.11	12.99	286	171	145	112	66.90	42.95	68.38	67.70	67.86	66.90	42.95
Other Long-Term Liabilities	3.97	7.58	4.38	15.72	25.41	18.29	36.98	60.98	6.13	6.56	6.27	5.94	5.58	21.74	6.56	6.27
Total Liabilities	41.07	51.26	147	99.75	140	509	437	422	339	278	252	327	318	321	278	252

Common Stock	0.01	0.02	0.02	0.03	0.03	0.03	0.03	--	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Retained Earnings	-4.05	16.45	46.55	84.81	150	236	372	485	102	18.62	21.30	108	116	125	18.62	21.30
Additional Paid-In Capital	55.47	132	147	280	298	326	364	407	432	451	456	437	441	446	451	456
Treasury Stock	-0.03	-0.03	-0.03	-0.38	-0.44	-0.62	-0.74	-14.02	-15.77	-17.12	-17.12	-16.04	-17.01	-17.03	-17.12	-17.12
Total Equity	51.40	148	193	364	447	561	735	878	519	452	460	529	540	555	452	460
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	8.41	20.50	30.10	38.26	65.11	86.68	136	113	-382	-98.58	-102	5.46	7.97	10.00	-122	2.13
Depreciation, Depletion and Amortization	3.07	4.13	6.97	10.56	13.77	20.41	28.31	34.59	39.56	40.06	40.02	10.17	9.91	9.98	10.01	10.12
Cash Flow from Others	10.31	5.08	6.47	-5.73	14.20	43.65	83.12	58.41	484	128	152	-3.76	5.28	1.91	125	20.16
Cash Flow from Operations	21.79	29.71	43.54	43.08	93.09	151	248	206	142	69.49	90.04	11.87	23.15	21.88	12.59	32.42

Investment for Property, Plant & Equipement	-1.79	-5.23	-20.39	-29.27	-28.63	-33.12	-41.57	-66.35	-44.42	-48.26	-48.10	-10.24	-10.01	-11.96	-16.06	-10.07
Cash Flow from Acquisitions	-6.77	-29.82	-145	-14.08	-102	-471	-53.57	-3.82	-132	-12.50	-13.13	--	-8.39	-0.35	-3.76	-0.63
Cash Flow from Investing	-8.33	-34.95	-133	-48.06	-124	-506	-97.26	-73.62	-181	-59.99	-66.77	-10.05	-17.88	-12.32	-19.74	-16.83

Net Issuance of Stock	23.07	72.16	5.50	129	6.33	3.81	5.34	-5.59	5.15	3.91	3.79	0.96	1.02	0.96	0.98	0.84
Net Issuance of Debt	-5.67	-6.08	44.98	-52.02	-4.78	300	-129	-44.84	-37.49	-44.44	-59.84	-8.55	-8.49	-8.45	-18.95	-23.95
Cash Flow for Dividends	--	--	--	--	--	--	--	-0.30	-0.70	-0.32	-0.32	--	-0.11	--	-0.22	--
Other Financing	-5.95	-0.39	-1.77	-5.31	1.66	-2.37	5.28	3.89	-0.21	-2.11	-1.16	-0.94	-1.83	-0.12	0.78	0.00
Cash Flow from Financing	11.46	65.69	48.71	71.97	3.21	302	-119	-46.85	-33.24	-42.96	-57.54	-8.53	-9.41	-7.62	-17.41	-23.12

Net Change in Cash	24.92	60.45	-40.45	66.99	-28.03	-53.34	31.64	85.81	-72.29	-33.46	-34.27	-6.71	-4.13	1.95	-24.56	-7.52

Free Cash Flow	20.00	24.48	23.15	13.81	64.45	118	206	140	97.25	21.23	41.94	1.64	13.15	9.93	-3.47	22.34
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

AMED Quarterly/Annuals Reports

AMED: 10-Q - AMEDISYS INC (0000896262) (Filer): (10-Q) - 2012-11-06
AMED: 10-Q - AMEDISYS INC (0000896262) (Filer): (10-Q) - 2012-08-07
AMED: 10-Q - AMEDISYS INC (0000896262) (Filer): (10-Q) - 2012-05-09
AMED: 10-K - AMEDISYS INC (0000896262) (Filer): (10-K) - 2012-02-28
AMED: 10-Q - AMEDISYS INC (0000896262) (Filer): (10-Q) - 2011-11-01

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

AMED Quarterly/Annuals Reports